Related Experiment Videos
Interferon-alpha/beta-receptor interactions: a complex story unfolding
Raj Deonarain1, David C M Chan, Leonidas C Platanias
1Toronto General Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada. raj.deonarain@utoronto.ca
Current Pharmaceutical Design
|October 9, 2002
Summary
Type I interferons (IFN-alpha/beta) have diverse effects, activating the same receptor complex differently. Key amino acid differences in these interferons dictate receptor interactions and biological responses.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Type I interferons (IFN-alpha/beta) display a wide range of biological activities.
- Different subtypes of IFN-alpha/beta activate the same cell surface receptor complex.
- Variable cellular responses are observed despite the shared receptor complex.
Purpose of the Study:
- To review the interactions between Type I interferons and their receptors.
- To identify critical amino acid residues involved in IFN-receptor binding.
- To explore the potential for ligand modification to enhance interferon bioactivity.
Main Methods:
- Literature review of studies on IFN-receptor interactions.
- Analysis of structural and functional data on IFN subtypes.
- Discussion of mutagenesis and bioactivity enhancement strategies.
Main Results:
- Distinct amino acid differences among IFN-alpha and IFN-beta subtypes influence ligand-receptor binding.
- Specific residues are critical for mediating variable biological responses.
- Understanding these interactions provides a basis for targeted modifications.
Conclusions:
- The specific amino acid residues in Type I interferons are crucial determinants of receptor interaction specificity.
- Targeted modifications of these residues hold potential for developing enhanced interferon therapeutics.
- Further research into IFN-receptor interactions can lead to improved bioactivity and therapeutic applications.